On November 17, 2022, CANARIABIO Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
994 KRW | +8.52% | -.--% | -80.70% |
29/03 | CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index | CI |
24/01 | Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis | MT |
1st Jan change | Capi. | |
---|---|---|
-80.70% | 137M | |
+19.15% | 12.44B | |
+3.76% | 5.98B | |
+4.98% | 5.27B | |
+12.24% | 4.62B | |
-19.13% | 2.71B | |
+2.71% | 1.93B | |
-13.33% | 1.24B | |
-17.39% | 942M | |
-9.93% | 935M |
- Stock Market
- Equities
- A016790 Stock
- News CANARIABIO Inc.
- CANARIABIO Inc. announced that it has received KRW 20 billion in funding from CANARIABIO M Inc.